Literature DB >> 16449643

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.

Hsin-Sheng Yang1, Connie P Matthews, Timothy Clair, Qing Wang, Alyson R Baker, Chou-Chi H Li, Tse-Hua Tan, Nancy H Colburn.   

Abstract

Programmed cell death 4 (Pdcd4) suppresses neoplastic transformation by inhibiting the activation of c-Jun and consequently AP-1-dependent transcription. We report that Pdcd4 blocks c-Jun activation by inhibiting the expression of mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1)/hematopoietic progenitor kinase 1, a kinase upstream of Jun N-terminal kinase (JNK). cDNA microarray analysis of Pdcd4-overexpressing RKO human colon carcinoma cells revealed MAP4K1 as the sole target of Pdcd4 on the JNK activation pathway. Cotransfection of a MAP4K1 promoter-reporter with Pdcd4 demonstrated inhibition of transcription from the MAP4K1 promoter. Ectopic expression of Pdcd4 in metastatic RKO cells suppressed invasion. MAP4K1 activity is functionally significant in invasion, as overexpression of a dominant negative MAP4K1 (dnMAP4K1) mutant in RKO cells inhibited not only c-Jun activation but also invasion. Overexpression of a MAP4K1 cDNA in Pdcd4-transfected cells rescued the kinase activity of JNK. Thus, Pdcd4 suppresses tumor progression in human colon carcinoma cells by the novel mechanism of down-regulating MAP4K1 transcription, with consequent inhibition of c-Jun activation and AP-1-dependent transcription.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449643      PMCID: PMC1367180          DOI: 10.1128/MCB.26.4.1297-1306.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1.

Authors:  J Liou; F Kiefer; A Dang; A Hashimoto; M H Cobb; T Kurosaki; A Weiss
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

Review 2.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

3.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

Review 4.  The AP-1 site and MMP gene regulation: what is all the fuss about?

Authors:  U Benbow; C E Brinckerhoff
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

5.  Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase.

Authors:  P Ling; Z Yao; C F Meyer; X S Wang; W Oehrl; S M Feller; T H Tan
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 8.  Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

Authors:  B W Ozanne; L McGarry; H J Spence; I Johnston; J Winnie; L Meagher; G Stapleton
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

9.  HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.

Authors:  F Kiefer; L A Tibbles; M Anafi; A Janssen; B W Zanke; N Lassam; T Pawson; J R Woodgett; N N Iscove
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

10.  Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors.

Authors:  Y Onishi; H Kizaki
Journal:  Biochem Biophys Res Commun       Date:  1996-11-01       Impact factor: 3.575

View more
  93 in total

1.  Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA.

Authors:  K Eto; S Goto; W Nakashima; Y Ura; S-I Abe
Journal:  Cell Death Differ       Date:  2011-09-30       Impact factor: 15.828

2.  Reduced expression of an RNA-binding protein by prolactin leads to translational silencing of programmed cell death protein 4 and apoptosis in newt spermatogonia.

Authors:  Ko Eto; Kazufumi Eda; Motoshi Hayano; Syota Goto; Kenta Nagao; Toshihiro Kawasaki; Hiroshi Kashimura; Hiroshi Tarui; Osamu Nishimura; Kiyokazu Agata; Shin-Ichi Abe
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

3.  MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Authors:  Hui Meng; Kai Wang; Xuedan Chen; Xingying Guan; Liwen Hu; Gang Xiong; Juan Li; Yun Bai
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Authors:  Marta M Fay; James M Clegg; Kimberly A Uchida; Matthew A Powers; Katharine S Ullman
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma.

Authors:  Cheng Qi; Yi Shao; Ning Li; Chunyan Zhang; Miaoqing Zhao; Fei Gao
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

6.  Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia.

Authors:  Xia Zhang; Riming Liu; Baohua Huang; Xiaolu Zhang; Weijuan Yu; Cuixia Bao; Jie Li; Chengming Sun
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

7.  Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.

Authors:  Hua Wang; Xianzhou Song; Craig Logsdon; Guisheng Zhou; Douglas B Evans; James L Abbruzzese; Stanley R Hamilton; Tse-Hua Tan; Huamin Wang
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

8.  Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.

Authors:  René Nieves-Alicea; Nancy H Colburn; Ann-Marie Simeone; Ana M Tari
Journal:  Breast Cancer Res Treat       Date:  2008-04-04       Impact factor: 4.872

9.  A network model of a cooperative genetic landscape in brain tumors.

Authors:  Markus Bredel; Denise M Scholtens; Griffith R Harsh; Claudia Bredel; James P Chandler; Jaclyn J Renfrow; Ajay K Yadav; Hannes Vogel; Adrienne C Scheck; Robert Tibshirani; Branimir I Sikic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

10.  Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.

Authors:  Young Mi Park; Su Jin Hwang; Kiyoshi Masuda; Kyung-Min Choi; Mi-Ran Jeong; Do-Hyun Nam; Myriam Gorospe; Hyeon Ho Kim
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.